Optimization and scale-up isolation and culture of neonatal porcine islets: Potential for clinical application

Cell Transplantation

Volumn 25, Issue 3, 2016, Pages 539-547

  Ellis, Cara ^a,b   Lyon, James G ^b   Korbutt, Gregory S ^a,b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Islet isolation; Islet transplantation; Neonatal porcine islets (NPIs)

Indexed keywords

BOVINE SERUM ALBUMIN; CASPASE INHIBITOR; COLLAGENASE; GLUCOSE; HUMAN SERUM ALBUMIN; INSULIN; PROTEINASE INHIBITOR; BENZYLOXYCARBONYLVALYL-ALANYL-ASPARTYL FLUOROMETHYL KETONE; CULTURE MEDIUM; PEPTIDE CHLOROMETHYL KETONE; SERUM ALBUMIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CULTURE OPTIMIZATION; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; ISOLATION PROCEDURE; MALE; NEONATAL PORCINE ISLET; NEWBORN; NONHUMAN; PANCREAS ISLET; PANCREAS ISLET BETA CELL; PIGLET; PRIORITY JOURNAL; SCALE UP; TISSUE CULTURE; ANIMAL; CULTURE MEDIUM; CYTOLOGY; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; DRUG EFFECTS; HUMAN; METABOLISM; MOUSE; PANCREAS ISLET TRANSPLANTATION; PHARMACOLOGY; PHYSIOLOGY; PIG; PROCEDURES; TISSUE CULTURE TECHNIQUE; XENOGRAFT;

AMINO ACID CHLOROMETHYL KETONES; ANIMALS; ANIMALS, NEWBORN; CASPASE INHIBITORS; CULTURE MEDIA; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; INSULIN; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; MALE; MICE; SERUM ALBUMIN; SWINE; TISSUE CULTURE TECHNIQUES; TRANSPLANTATION, HETEROLOGOUS;

EID: 84977596625     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368915X689451     Document Type: Article

References (38)

1. Arefanian, H.; Tredget, E. B.; Rajotte, R. V.; Gill, R. G.; Korbutt, G. S.; Rayat, G. R. Short-term administrations of a combination of anti-LFA-1 and anti-CD154 monoclonal antibodies induce tolerance to neonatal porcine islet xenografts in mice. Diabetes 59(4):958–966; 2010.
2. Bonner-Weir, S.; Inada, A.; Yatoh, S.; Li, W. C.; Aye, T.; Toschi, E.; Sharma, A. Transdifferentiation of pancreatic ductal cells to endocrine beta-cells. Biochem. Soc. Trans. 36(Pt 3):353–356; 2008.
3. Bonner-Weir, S.; Taneja, M.; Weir, G. C.; Tatarkiewicz, K.; Song, K. H.; Sharma, A.; O’Neil, J. J. In vitro cultivation of human islets from expanded ductal tissue. Proc. Natl. Acad. Sci. USA 97(14):7999–8004; 2000.
4. Brandhorst, D.; Brandhorst, H.; Maataoui, V.; Maataoui, A.; Johnson, P. R. Anti-caspase-3 preconditioning increases proinsulin secretion and deteriorates posttransplant function of isolated human islets. Apoptosis 18(6):681–688; 2013.
5. Brandhorst, D.; Kumarasamy, V.; Maatoui, A.; Alt, A.; Bretzel, R. G.; Brandhorst, H. Porcine islet graft function is affected by pretreatment with a caspase-3 inhibitor. Cell Transplant. 15(4):311–317; 2006.
6. Bruni, A.; Pepper, A.; Gala-Lopez, B.; Pawlick, R.; Shapiro, A. Examining the utility of a catalytic antioxidant in islet transplantation. Transplantation 98:332–333; 2014.
7. Cardona, K.; Korbutt, G. S.; Milas, Z.; Lyon, J.; Cano, J.; Jiang, W.; Bello-Laborn, H.; Hacquoil, B.; Strobert, E.; Gangappa, S., Weber, C. J.; Pearson, T. C.; Rajotte, R. V.; Larsen, C. P. Long-term survival of neonatal porcine islets in nonhuman primates by targeting costimulation pathways. Nat. Med. 12(3):304–306; 2006.
8. Citro, A.; Cantarelli, E.; Piemonti, L. Anti-inflammatory strategies to enhance islet engraftment and survival. Curr. Diab. Rep. 13(5):733–744; 2013.
9. Dufrane, D.; D’Hoore, W.; Goebbels, R. M.; Saliez, A.; Guiot, Y.; Gianello, P. Parameters favouring successful adult pig islet isolations for xenotransplantation in pig-to-primate models. Xenotransplantation 13(3):204–214; 2006.
10. Eberhardt, M.; Salmon, P.; von Mach, M. A.; Hengstler, J. G.; Brulport, M.; Linscheid, P.; Seboek, D.; Oberholzer, J.; Barbero, A.; Martin, I.; Müller, B.; Trono, D.; Zulewski, H. Multipotential nestin and Isl-1 positive mesenchymal stem cells isolated from human pancreatic islets. Biochem. Biophys. Res. Commun. 345(3):1167–1176; 2006.
11. Emamaullee, J. A.; Shapiro, A. M. J.; Rajotte, R. V.; Korbutt, G.; Elliott, J. F. Neonatal porcine islets exhibit natural resistance to hypoxia-induced apoptosis. Transplantation 82(7):945–952; 2006.
12. Garkavenko, O.; Durbin, K.; Tan, P.; Elliott, R. Islets transplantation: New Zealand experience. Xenotransplantation 18(1):60–60; 2011.
13. Gorantla, V. S.; Schneeberger, S.; Moore, L. R.; Donnenberg, V. S.; Zimmerlin, L.; Lee, W. P. A.; Donnenberg, A. D. Development and validation of a procedure to isolate viable bone marrow cells from the vertebrae of cadaveric organ donors for composite organ grafting. Cytotherapy 14(1):104–113; 2012.
14. Harb, G.; Toreson, J.; Dufour, J.; Korbutt, G. Acute exposure to streptozotocin but not human proinflammatory cytokines impairs neonatal porcine islet insulin secretion in vitro but not in vivo. Xenotransplantation 14(6):580–590; 2007.
15. Heremans, Y.; Van De Casteele, M.; In’t Veld, P.; Gradwohl, G.; Serup, P.; Madsen, O.; Pipeleers, D.; Heimberg, H. Recapitulation of embryonic neuroendocrine differentiation in adult human pancreatic duct cells expressing neurogenin 3. J. Cell. Biol. 159(2):303–312; 2002.
16. Hering, B. J.; Kandaswamy, R.; Ansite, J. D.; Eckman, P. M.; Nakano, M.; Sawada, T.; Matsumoto, I.; Ihm, S. H.; Zhang, H. J.; Parkey, J.; Hunter, D. W.; Sutherland, D. E. Single-donor, marginal-dose islet transplantation in patients with type 1 diabetes. JAMA 293(7):830–835; 2005.
17. Inada, A.; Nienaber, C.; Katsuta, H.; Fujitani, Y.; Levine, J.; Morita, R.; Sharma, A.; Bonner-Weir, S. Carbonic anhydrase II-positive pancreatic cells are progenitors for both endocrine and exocrine pancreas after birth. Proc. Natl. Acad. Sci. USA 105(50):19915–19919; 2008.
18. Kin, T.; Korbutt, G. S. Delayed functional maturation of neonatal porcine islets in recipients under strict glycemic control. Xenotransplantation 14(4):333–338; 2007.
19. Kin, T.; Korbutt, G. S.; Kobayashi, T.; Dufour, J. M.; Rajotte, R. V. Reversal of diabetes in pancreatectomized pigs after transplantation of neonatal porcine islets. Diabetes 54(4):1032–1039; 2005.
20. Korbutt, G. S.; Elliott, J. F.; Ao, Z. L.; Smith, D. K.; Warnock, G. L.; Rajotte, R. V. Large scale isolation, growth, and function of porcine neonatal islet cells. J. Clin. Invest. 97(9):2119–2129; 1996.
21. Korsgren, O.; Lundgren, T.; Felldin, M.; Foss, A.; Isaksson, B.; Permert, J.; Persson, N. H.; Rafael, E.; Ryden, M.; Salmela, K.; Tibell, A.; Tufveson, G.; Nilsson, B. Optimising islet engraftment is critical for successful clinical islet transplantation. Diabetologia 51(2):227–232; 2008.
22. Kuehn, C.; Lakey, J. R.; Lamb, M. W.; Vermette, P. Young porcine endocrine pancreatic islets cultured in fibrin show improved resistance toward hydrogen peroxide. Islets 5(5):207–215; 2013.
23. Lamb, M.; Laugenour, K.; Liang, O.; Alexander, M.; Foster, C. E.; Lakey, J. R. In vitro maturation of viable islets from partially digested young pig pancreas. Cell Transplant. 23(3):263–272; 2014.
24. McCall, M.; Toso, C.; Emamaullee, J.; Pawlick, R.; Edgar, R.; Davis, J.; Maciver, A.; Kin, T.; Arch, R.; Shapiro, A. M. The caspase inhibitor IDN-6556 (PF3491390) improves marginal mass engraftment after islet transplantation in mice. Surgery 150(1):48–55; 2011.
25. Montolio, M.; Tellez, N.; Biarnes, M.; Soler, J.; Montanya, E. Short-term culture with the caspase inhibitor z-VAD. fmk reduces beta cell apoptosis in transplanted islets and improves the metabolic outcome of the graft. Cell Transplant. 14(1):59–65; 2005.
26. Potter, K. J.; Abedini, A.; Marek, P.; Klimek, A. M.; Butterworth, S.; Driscoll, M.; Baker, R.; Nilsson, M. R.; Warnock, G. L.; Oberholzer, J.; Bertera, S.; Trucco, M.; Korbutt, G. S.; Fraser, P. E.; Raleigh, D. P.; Verchere, C. B. Islet amyloid deposition limits the viability of human islet grafts but not porcine islet grafts. Proc. Natl. Acad. Sci. USA 107(9):4305–4310; 2010.
27. Rajaraman, G.; White, J.; Tan, K. S.; Ulrich, D.; Rosamilia, A.; Werkmeister, J.; Gargett, C. E. Optimization and scale-up culture of human endometrial multipotent mesenchymal stromal cells: Potential for clinical application. Tissue Eng. Part C Methods 19(1):80–92; 2013.
28. Ryan, E. A.; Lakey, J. R.; Paty, B. W.; Imes, S.; Korbutt, G. S.; Kneteman, N. M.; Bigam, D.; Rajotte, R. V.; Shapiro, A. M. Successful islet transplantation—Continued insulin reserve provides long-term glycemic control. Diabetes 51(7):2148–2157; 2002.
29. Ryan, E. A.; Lakey, J. R.; Rajotte, R. V.; Korbutt, G. S.; Kin, T.; Imes, S.; Rabinovitch, A.; Elliott, J. F.; Bigam, D.; Kneteman, N. M.; Warnock, G. L.; Larsen, I.; Shapiro, A. M. Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol. Diabetes 50(4):710–719; 2001.
30. Ryan, E. A.; Paty, B. W.; Senior, P. A.; Bigam, D.; Alfadhli, E.; Kneteman, N. M.; Lakey, J. R.; Shapiro, A. M. Fiveyear follow-up after clinical islet transplantation. Diabetes 54(7):2060–2069; 2005.
31. Seaberg, R. M.; Smukler, S. R.; Kieffer, T. J.; Enikolopov, G.; Asghar, Z.; Wheeler, M. B.; Korbutt, G.; van der Kooy, D. Clonal identification of multipotent precursors from adult mouse pancreas that generate neural and pancreatic lineages. Nat. Biotechnol. 22(9):1115–1124; 2004.
32. Shapiro, A. M.; Lakey, J. R.; Ryan, E. A.; Korbutt, G. S.; Toth, E.; Warnock, G. L.; Kneteman, N. M.; Rajotte, R. V. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N. Engl. J. Med. 343(4):230–238; 2000.
33. Shapiro, A. M. J.; Ricordi, C.; Hering, B. J.; Auchincloss, H.; Lindblad, R.; Robertson, P.; Secchi, A.; Brendel, M. D.; Berney, T.; Brennan, D. C.; Cagliero, E.; Alejandro, R.; Ryan, E. A.; DiMercurio, B.; Morel, P.; Polonsky, K. S.; Reems, J. A.; Bretzel, R. G.; Bertuzzi, F.; Froud, T.; Kandaswamy, R.; Sutherland, D. E.; Eisenbarth, G.; Segal, M.; Preiksaitis, J.; Korbutt, G. S.; Barton, F. B.; Viviano, L., Seyfert-Margolis, V.; Bluestone, J.; Lakey, J. R. International trial of the Edmonton protocol for islet transplantation. N. Engl. J. Med. 355(13):1318–1330; 2006.
34. Street, C. N.; Lakey, J. R.; Shapiro, A. M.; Imes, S.; Rajotte, R. V.; Ryan, E. A.; Lyon, J. G.; Kin, T.; Avila, J.; Tsujimura, T.; Korbutt, G. S. Islet graft assessment in the Edmonton Protocol: Implications for predicting long-term clinical outcome. Diabetes 53(12):3107–3114; 2004.
35. Thompson, P.; Cardona, K.; Russell, M.; Badell, I. R.; Shaffer, V.; Korbutt, G.; Rayat, G. R.; Cano, J.; Song, M.; Jiang, W.; Strobert, E.; Rajotte, R.; Pearson, T.; Kirk, A. D.; Larsen, C. P. CD40-specific costimulation blockade enhances neonatal porcine islet survival in nonhuman primates. Am. J. Transplant. 11(5):947–957; 2011.
36. Tsukada, M.; Saito, T.; Ise, K.; Kenjo, A.; Kimura, T.; Satoh, Y.; Saito, T.; Anazawa, T.; Oshibe, I.; Suzuki, S.; Hashimoto, Y.; Gotoh, M. A model to evaluate toxic factors influencing islets during collagenase digestion: The role of serine protease inhibitor in the protection of islets. Cell Transplant. 21(2–3):473–482; 2012.
37. Warnock, G. L.; Meloche, R. M.; Thompson, D.; Shapiro, J.; Fung, M.; Ao, Z. L.; Ho, S.; He, Z. H.; Dai, L. J.; Young, L.; Blackburn, L.; Kozak, S.; Kim, P. T.; Al-Adra, D.; Johnson, J. D.; Liao, Y. H.; Elliot, T.; Verchere, C. B. Improved human pancreatic islet isolation for a prospective cohort study of islet transplantation vs best medical therapy in type 1 diabetes mellitus. Arch. Surg. 140(8):735–742; 2005.
38. Yatoh, S.; Dodge, R.; Akashi, T.; Omer, A.; Sharma, A.; Weir, G. C.; Bonner-Weir, S. Differentiation of affinitypurified human pancreatic duct cells to beta-cells. Diabetes 56(7):1802–1809; 2007.